Get the Stockscreener App
0.8549
1.77%
0.0149
Estrella Immunopharma Inc stock is traded at $0.8549, with a volume of 10,927.
It is up +1.77% in the last 24 hours and down -0.69% over the past month.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
See More
Previous Close:
$0.84
Open:
$0.849
24h Volume:
10,927
Relative Volume:
0.06
Market Cap:
$30.92M
Revenue:
-
Net Income/Loss:
$-8.53M
P/E Ratio:
-3.5123
EPS:
-0.2434
Net Cash Flow:
$-12.75M
1W Performance:
-6.05%
1M Performance:
-0.69%
6M Performance:
-18.58%
1Y Performance:
-51.70%
1-Day Range:
$0.83
$0.87
1-Week Range:
$0.821
$0.95
52-Week Range:
$0.63
$1.78
Estrella Immunopharma Inc Stock (ESLA) Company Profile
Name
Estrella Immunopharma Inc
Sector
Industry
Phone
(510) 318-9098
Address
5858 HORTON STREET, SUITE 370, EMERYVILLE
Compare ESLA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ESLA
Estrella Immunopharma Inc
|
0.8549 | 30.38M | 0 | -8.53M | -12.75M | -0.2434 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Estrella Immunopharma Inc Stock (ESLA) Latest News
What Fibonacci levels say about Estrella Immunopharma Inc. reboundPattern Recognition Tool for ROI Investors - Newser
Analyzing recovery setups for Estrella Immunopharma Inc. investorsShort-Term Profit Alert With Entry Forecast - Newser
What earnings revisions data tells us about Estrella Immunopharma Inc.Day Trading Plan with Entry Risk Management - Newser
Advanced analytics toolkit walkthrough for Estrella Immunopharma Inc.AI Intraday Market Movement Prediction Tool - Newser
Can Estrella Immunopharma Inc. rally from current levelsBuy Opportunity Forecast for Fast Traders - Newser
Understanding Estrella Immunopharma Inc.’s price movementSwing Gain Strategy with Entry Forecast - Newser
What are analysts’ price targets for Estrella Immunopharma Inc. in the next 12 monthsEarnings Report Tips Backed By Experts - jammulinksnews.com
Is it the right time to buy Estrella Immunopharma Inc. stockBreakout Stocks Opportunities Backed By Experts - jammulinksnews.com
Using data filters to optimize entry into Estrella Immunopharma Inc.AI Enhanced Strategy for Portfolio Growth - Newser
Is Estrella Immunopharma Inc. forming a reversal patternFree Weekly Chart Analysis With Entry Advice - Newser
Why Estrella Immunopharma Inc. stock attracts strong analyst attentionFree Low Capital High Return Stock Plans - Newser
How Estrella Immunopharma Inc. stock performs during market volatilityPredictive Model for Intraday Swing Forecast - Newser
Estrella Immunopharma Inc. Sees Relief Buying After Extended DropLow Risk Equity Screener With Results Shared - metal.it
Published on: 2025-07-29 20:37:12 - metal.it
Published on: 2025-07-29 17:11:34 - metal.it
Visualizing Estrella Immunopharma Inc. stock with heatmapsWeekly Hot Stocks Based on Volume Flow - Newser
What are Estrella Immunopharma Inc. company’s key revenue driversStock Market Ideas With Proven Results - jammulinksnews.com
What makes Estrella Immunopharma Inc. stock price move sharplyAchieve unparalleled market performance - jammulinksnews.com
What are the latest earnings results for Estrella Immunopharma Inc.Maximize portfolio value with smart investment plans - jammulinksnews.com
Competitive Positioning of Estrella Immunopharma Inc.: Is It Leading or LaggingAI Entry Timing Prediction for Swing Traders - Newser
What is Estrella Immunopharma Inc. company’s growth strategyMarket-beating performance - jammulinksnews.com
When is Estrella Immunopharma Inc. stock expected to show significant growthMaximize gains with timely market signals - jammulinksnews.com
How does Estrella Immunopharma Inc. generate profit in a changing economyDiscover stocks with strong growth potential - jammulinksnews.com
Is Estrella Immunopharma Inc. stock overvalued or undervaluedBuild a portfolio that outperforms the market - jammulinksnews.com
Why is Estrella Immunopharma Inc. stock attracting strong analyst attentionFree Buy/Sell Signal Notifications - jammulinksnews.com
How does Estrella Immunopharma Inc. compare to its industry peersStay ahead with advanced stock screening tools - jammulinksnews.com
What is the dividend policy of Estrella Immunopharma Inc. stockAchieve remarkable returns with smart investing - jammulinksnews.com
Buy Signal for Estrella Immunopharma Inc. Stock Key Technical Indicators to WatchCapital Safe Stock Watchlist - Newser
How strong is Estrella Immunopharma Inc. company’s balance sheetDiscover stocks with strong growth potential - jammulinksnews.com
Is Estrella Immunopharma Inc. stock overhyped or has real potential Free Weekly Stock Watch With Growth Focus - Newser
Published on: 2025-07-27 16:10:25 - jammulinksnews.com
Estrella Immunopharma Inc Stock (ESLA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):